Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Post by broxburnboyon Apr 13, 2007 10:59am
333 Views
Post# 12601298

Bottom fishing

Bottom fishingThe recent private placement of shares was at .50$. Any price below this I view as a great buying opportunity. Large private investors do a lot more due diligence and usually get a pretty sweet deal on a large chunk of new shares. SSS is going to require more cash in the near future and is likely looking to do another private placement. News of such a placement at a higher price, particularly with an institutional investor who are more likely to do thorough DD, will be the next catalyst for an upside move on the Stock Price. My advice... hold and buy more on price weakness
Bullboard Posts